YOUR BUSINESS AUTHORITY
Springfield, MO
U.S. regulators approved the first new treatment for Alzheimer's disease in nearly 20 years.
Biogen Inc.'s aducanumab medication is designed to target the underlying cause of Alzheimer's.
Scientists reportedly are divided over the treatment's potential impact due to uncertain trial results.
Read more from BBC News.
Organizers hope to bolster client traffic to center city businesses.
SBJ announces executive newsroom hires
Timeshare exit company owner sentenced for tax evasion
Trump, fast-food companies among targets of X redirects
Stockton district names next superintendent
State awards Springfield $4.6M for wastewater system improvements
Council modifies data center definitions bill, extends moratorium into next year